Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.

I Relaño-RodríguezM S Espinar-BuitragoV Martín-CañadillaR Gómez-RamirezJ L JiménezMaria Angeles Muñoz-Fernández

Published in: Journal of nanobiotechnology (2021)

Nanotechnology, in particular polyanionic carbosilane dendrimers, have proved their potential application against HCMV, being capable of inhibiting the infection by themselves or enhancing the activity of ganciclovir, the actual treatment. These compounds represent a low-cost approach to fight HCMV infections.

Keyphrases

low cost
endothelial cells
signaling pathway
induced pluripotent stem cells
pluripotent stem cells
human health
risk assessment
replacement therapy